← back to search

Hong C. Shen

Hangzhou Medical College · CN
🔎 Find collaborators in Organic Chemistry →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Organic Chemistry
Research interest
Research interests include Catalytic C–H Functionalization Methods, Synthetic Organic Chemistry Methods, Cyclopropane Reaction Mechanisms, and Catalytic Alkyne Reactions.
h-index
42
citations
6,361
works
172
NIH funding
primary concept
Chemistry
email

Recent publications

Discovery of Potent and Efficacious Influenza PB2 Inhibitors.
2026cited by 0position: contributordoi
Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy.
2026cited by 0position: contributordoi
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor Efficacy.
2025cited by 6position: contributordoi
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection.
2023cited by 24position: contributordoi
Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus.
2023cited by 4position: contributordoi
Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection.
2022cited by 12position: contributordoi
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling
Cell Reports 2020cited by 171position: middledoi
Discovery of Pyrido[2,3-<i>b</i>]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV.
2020cited by 46position: contributordoi
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors.
2020cited by 16position: contributordoi
Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.
2019cited by 70position: contributordoi
A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.
2019cited by 9position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2019–2026)Xuefei Tan · Roche (China)6 papers (2020–2026)Wei Zhu · American Chemical Society6 papers (2019–2026)Jun Wu · Shanghai University3 papers (2025–2026)Shuai Chen · Novoprotein Scientific (Shanghai) Inc2 papers (2025–2026)Rohit Reja · Gene Therapy Laboratory1 papers (2020–2020) · 1 papers (2020–2020)Paul Beroza · Gene Therapy Laboratory1 papers (2020–2020)Taishan Hu · Southwestern Medical Center1 papers (2020–2020) · 1 papers (2020–2020)James J. Crawford · Genesys (United States)1 papers (2020–2020)Yue Zhang · Union Hospital1 papers (2020–2020)Wendy Lee · Gene Therapy Laboratory1 papers (2020–2020)Tao Guo · Jiangnan University1 papers (2019–2019)Bernd Kuhn · American Chemical Society1 papers (2020–2020)Fabian Dey · Roche (Switzerland)1 papers (2025–2025)Guozhi Tang · American Chemical Society1 papers (2019–2019)S. Frank Yan · Fudan University1 papers (2020–2020)Hongying Yun · American Chemical Society1 papers (2019–2019)John A.T. Young · Johns Hopkins University1 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Organic Chemistry →